0001250853-13-000111.txt : 20131107
0001250853-13-000111.hdr.sgml : 20131107
20131107202046
ACCESSION NUMBER: 0001250853-13-000111
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131105
FILED AS OF DATE: 20131107
DATE AS OF CHANGE: 20131107
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lion Biotechnologies, Inc.
CENTRAL INDEX KEY: 0001425205
STANDARD INDUSTRIAL CLASSIFICATION: ARRANGEMENT OF TRANSPORTATION OF FREIGHT & CARGO [4731]
IRS NUMBER: 753254381
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21900 BURBANK BLVD.
STREET 2: THIRD FLOOR
CITY: WOODLAND HILLS
STATE: CA
ZIP: 91367
BUSINESS PHONE: 818-992-3126
MAIL ADDRESS:
STREET 1: 21900 BURBANK BLVD.
STREET 2: THIRD FLOOR
CITY: WOODLAND HILLS
STATE: CA
ZIP: 91367
FORMER COMPANY:
FORMER CONFORMED NAME: Genesis Biopharma, Inc
DATE OF NAME CHANGE: 20100319
FORMER COMPANY:
FORMER CONFORMED NAME: FREIGHT MANAGEMENT CORP
DATE OF NAME CHANGE: 20080128
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Singh Manish
CENTRAL INDEX KEY: 0001550588
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-53127
FILM NUMBER: 131202301
MAIL ADDRESS:
STREET 1: 21900 BURBANK BOULEVARD, 3RD FLOOR
CITY: WOODLAND HILLS
STATE: CA
ZIP: 91367
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2013-11-05
0
0001425205
Lion Biotechnologies, Inc.
LBIO
0001550588
Singh Manish
21900 BURBANK BOULEVARD, 3RD FLOOR
WOODLAND HILLS
CA
91367
1
1
1
0
President & CEO
Common Stock
2013-11-05
4
A
0
607500
A
1813500
D
Common Stock
2013-11-05
4
P
0
125000
2
A
1938500
D
Warrant
2.5
2013-11-05
4
A
0
125000
A
2013-11-05
2018-11-05
Common stock
125000
125000
D
These shares were issued to the reporting person pursuant to a merger agreement between Lion Biotechnologies, Inc. and Genesis Biopharma, Inc. dated July 24, 2013 whereby upon the completion of a financing within 12 months following the merger, additional shares would be issued to the reporting person. The Issuer completed a financing on November 5, 2013.
These warrant shares were acquired in a recent offering by the Issuer of common stock and warrants whereby a purchase of each share of common stock included a warrant exercisable for one share of common stock at $2.50 per share.
/s/ Manish Singh
2013-11-07